Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Incannex Healthcare (IXHL) EBITDA Margin (2024 - 2025)

Historic EBITDA Margin for Incannex Healthcare (IXHL) over the last 2 years, with Q4 2025 value amounting to 136160.0%.

  • Incannex Healthcare's EBITDA Margin rose 835933300.0% to 136160.0% in Q4 2025 from the same period last year, while for Dec 2025 it was 347030.0%, marking a year-over-year decrease of 3333346500.0%. This contributed to the annual value of 54302.33% for FY2025, which is 1001643400.0% up from last year.
  • Per Incannex Healthcare's latest filing, its EBITDA Margin stood at 136160.0% for Q4 2025, which was up 835933300.0% from 124000.0% recorded in Q3 2025.
  • Over the past 5 years, Incannex Healthcare's EBITDA Margin peaked at 136160.0% during Q4 2025, and registered a low of 124000.0% during Q3 2025.